Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)

PHASE2TerminatedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

March 25, 2019

Study Completion Date

March 25, 2019

Conditions
Painful Diabetic Neuropathy
Interventions
DRUG

EMA401

capsules, oral

DRUG

Placebo

Placebo to EMA401 capsules, oral

Trial Locations (64)

1000

Novartis Investigative Site, Sofia

1085

Novartis Investigative Site, Budapest

1089

Novartis Investigative Site, Budapest

1336

Novartis Investigative Site, Sofia

1407

Novartis Investigative Site, Sofia

1431

Novartis Investigative Site, Sofia

2143

Novartis Investigative Site, Kistarcsa

2292

Novartis Investigative Site, Broadmeadow

2500

Novartis Investigative Site, Esztergom

2650

Novartis Investigative Site, Edegem

2800

Novartis Investigative Site, Orange

3081

Novartis Investigative Site, Heidelberg Heights

3212

Novartis Investigative Site, Pellenberg

4000

Novartis Investigative Site, Liège

4032

Novartis Investigative Site, Debrecen

5000

Novartis Investigative Site, Adelaide

6720

Novartis Investigative Site, Szeged

6725

Novartis Investigative Site, Szeged

7632

Novartis Investigative Site, Pécs

8000

Novartis Investigative Site, Aarhus

8230

Novartis Investigative Site, Balatonfüred

9020

Novartis Investigative Site, Klagenfurt

24119

Novartis Investigative Site, Kiel

28222

Novartis Investigative Site, Madrid

40225

Novartis Investigative Site, Düsseldorf

41014

Novartis Investigative Site, Seville

45147

Novartis Investigative Site, Essen

65191

Novartis Investigative Site, Wiesbaden

83305

Novartis Investigative Site, Bratislava

85101

Novartis Investigative Site, Bratislava

92104

Novartis Investigative Site, Boulogne-Billancourt

98401

Novartis Investigative Site, Lučenec

4901858

Novartis Investigative Site, Viana do Castelo

A-8036

Novartis Investigative Site, Graz

A-1090

Novartis Investigative Site, Vienna

L4J 1W3

Novartis Investigative Site, Ontario

L4J 8L7

Novartis Investigative Site, Thornhill

M4G 3E8

Novartis Investigative Site, Toronto

H7T 2P5

Novartis Investigative Site, Laval

DK 2820

Novartis Investigative Site, Gentofte Municipality

DK 5000

Novartis Investigative Site, Odense C

FIN-33520

Novartis Investigative Site, Tampere

D 33647

Novartis Investigative Site, Bielefeld

06120

Novartis Investigative Site, Halle

Unknown

Novartis Investigative Site, Kassel

04109

Novartis Investigative Site, Leipzig

0450

Novartis Investigative Site, Oslo

31 505

Novartis Investigative Site, Krakow

15-351

Novartis Investigative Site, Bialystok

00 144

Novartis Investigative Site, Warsaw

2500 176

Novartis Investigative Site, Caldas da Rainha

1250 203

Novartis Investigative Site, Lisbon

4454 509

Novartis Investigative Site, Matosinhos Municipality

4200 319

Novartis Investigative Site, Porto

4434 502

Novartis Investigative Site, Vila Nova de Gaia

080 01

Novartis Investigative Site, Prešov

08001

Novartis Investigative Site, Prešov

BD9 6RJ

Novartis Investigative Site, Bradford

BA1 3NG

Novartis Investigative Site, Bath

BH7 7DW

Novartis Investigative Site, Bournemouth

EH4 2XU

Novartis Investigative Site, Edinburgh

SE1 7EH

Novartis Investigative Site, London

TS4 3BW

Novartis Investigative Site, Middlesbrough

OL1 2JH

Novartis Investigative Site, Oldham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY